Therapeutics: E1A binding protein p300 (EP300; p300); CREB binding protein (CREBBP; CBP)

Cancer

INDICATION: Cancer; leukemia

Cell culture and mouse studies suggest inhibiting EP300 could help treat CREBBP-deficient cancers. In

Read the full 160 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE